Advertisement

Topics

TiGenix opens US headquarters

10:00 EDT 30 Jun 2017 | Bionity

TiGenix NV announces it has opened an U.S. office in Cambridge, Massachusetts. Establishing U.S. operations is a significant step for TiGenix and will support its strategic goal of developing and commercializing its lead product, Cx601, for the treatment of complex perianal fistulas in Crohn's disea...

Original Article: TiGenix opens US headquarters

NEXT ARTICLE

More From BioPortfolio on "TiGenix opens US headquarters"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topic

Crohn's Disease (CD)
Crohn’s disease (CD) is a long-term condition that causes inflammation of the lining of the digestive system.  Inflammation can affect any part of the digestive system, from the mouth to the back passage, but most commonly occurs in the last s...